Class Certification of Third-Party Payors Denied in Neurontin Marketing Suit



DOCUMENTS
  • Order


BOSTON - A Massachusetts federal judge on May 13 denied class certification to a group of consumers and third-party payors who paid for Neurontin prescriptions, finding that individualized issues overwhelm common questions. In re Neurontin Marketing, Sales Practices and Products Liability Litigation, MDL No. 1629 (D. Mass.).

U.S. District Judge Patti B. Saris of the U.S. District Court for the District of Massachusetts noted that it would be better for the TPPs to seek reimbursement from defendants Pfizer and Warner-Lambert in individualized lawsuits.

The proposed class accuses the defendants of fraudulently marketing and selling Neurontin for "off-label" uses not approved …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024

MORE DETAILS



HarrisMartin's Webinar Series: Video Game Addiction Product Liability Litigation

March 29, 2024

MORE DETAILS